Ganitumab

ganitumab · Amgen

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Ganitumab, covering 2015-07-20 to 2024-11-08. Get the full timeline:

Most recent: Clinical Trial Update: Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas [Phase 2]